Other Solvents
Aobchem N-(3-Methoxyphenyl)cyclohexanecarboxamide | ≥95% | CAS 315712-25-5 | C14H19NO2 | 500mg
N-(3-Methoxyphenyl)cyclohexanecarboxamide | ≥95% | CAS 315712-25-5 | C14H19NO2 | 500mg
Aobchem N-(3-Methoxyphenyl)cyclohexanecarboxamide | ≥95% | CAS 315712-25-5 | C14H19NO2 | 10g
N-(3-Methoxyphenyl)cyclohexanecarboxamide | ≥95% | CAS 315712-25-5 | C14H19NO2 | 10g
eMolecules 32529-79-6 | 4-Carbomethoxy-cyclohexane-1-carboxylic acid | Combi-Blocks | MFCD06797561 | 186.207 | C9H14O4 | 97.000 | COC(=O)C1CCC(CC1)C(O)=O | 25g | 448006498
4-Carbomethoxy-cyclohexane-1-carboxylic acid | Combi-Blocks | 32529-79-6 | MFCD06797561 | 186.207 | C9H14O4 | 97.000 | COC(=O)C1CCC(CC1)C(O)=O | 25g | 448006498
eMolecules 1187927-93-0 | N,N-Diethyl-cyclohexane-1,4-diamine dihydrochloride | J & W PharmLab, LLC | MFCD08752576 | 243.220 | C10H24Cl2N2 | 96.000 | Cl.Cl.CCN(CC)C1CCC(N)CC1 | 5g | 250001505
N,N-Diethyl-cyclohexane-1,4-diamine dihydrochloride | J & W PharmLab, LLC | 1187927-93-0 | MFCD08752576 | 243.220 | C10H24Cl2N2 | 96.000 | Cl.Cl.CCN(CC)C1CCC(N)CC1 | 5g | 250001505
Medchemexpress LLC Cyclohexane-1,4-diamine | 3114-70-3 | 114.19 | 25 G
Cyclohexane-1,4-diamine (1,4-Diaminocyclohexane) is a PROTAC Linker used in PROTAC synthesis. This product is intended for research purposes only and is not for patient use.
- Functions as a PROTAC linker
- Suitable for PROTAC synthesis
- Intended for research use only
eMolecules 1823244-92-3 | DITERT-BUTYL CYCLOHEXANE-1,3-DIYLDICARBAMATE | MFCD18252218 | 1g
Ambeed | 6-Bromo-4H-imidazo[45-b]pyridine | 1g | 552576084 | A140120 | 28279-49-4 | MFCD00460092 | 198.023 | C6H4BrN3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC trans-Cyclohexane-1,2-diol | 1460-57-7 | MFCD00066430 | 99.9% | 116.16 | 10 G
trans-Cyclohexane-1,2-diol (TCHD) acts as a transient dilator of the nuclear pore complex (NPC). It interacts with the hydrophobic core (FG nucleoporin) of the NPC, which disrupts the NPC structure and reversibly increases the nuclear pore's permeability. This allows macromolecules larger than 40 kDa (such as plasmid DNA) to enter the cell nucleus via passive diffusion, thereby enhancing the nuclear import efficiency of non-viral vectors.
- Can improve the efficiency of in vitro electrotransfection or lipid-mediated gene transfection.
- Significantly increases gene expression in differentiated airway epithelial cells.
- Allows macromolecules larger than 40 kDa to enter the cell nucleus.
- Disrupts NPC structure and reversibly increases nuclear pore's permeability.
Cambridge Isotope Laboratories Cyclohexane-1 2-dicarboxylic acid mono-(4-methyl octyl) ester (MINCH) (13C4 99%) 100 ug/mL in MTBE 1 2 mL
Cyclohexane-1 2-dicarboxylic acid mono-(4-methyl octyl) ester (MINCH) (13C4 99%) 100 ug/mL in MTBE 1 2 mL
Apexbio Technology LLC trans-Cyclohexane-1-2-diol
trans-Cyclohexane-1 2-diol (CAS No 1460-57-7) is a biologically relevant compound studied in the field of biomedical research particularly for its potential therapeutic applications due to its unique stereochemistry Its mechanism of action involves modulating biochemical pathways associated with oxidative stress and metabolic regulation It has demonstrated activity within the nanomolar to low micromolar range indicating significant potency in cellular environments This compound is used in various in vitro models to assess its efficacy in reducing oxidative damage or modulating metabolic pathways and in vivo animal studies often explore its pharmacokinetics and potential drug interactions Additionally trans-Cyclohexane-1 2-diol is frequently used in drug screening programs to evaluate its impact on cell viability and its potential as a lead compound for therapeutic development Experimental concentrations typically depend on the specific research design
Apexbio Technology LLC trans-Cyclohexane-1-2-diol
trans-Cyclohexane-1 2-diol (CAS No 1460-57-7) is a biologically relevant compound studied in the field of biomedical research particularly for its potential therapeutic applications due to its unique stereochemistry Its mechanism of action involves modulating biochemical pathways associated with oxidative stress and metabolic regulation It has demonstrated activity within the nanomolar to low micromolar range indicating significant potency in cellular environments This compound is used in various in vitro models to assess its efficacy in reducing oxidative damage or modulating metabolic pathways and in vivo animal studies often explore its pharmacokinetics and potential drug interactions Additionally trans-Cyclohexane-1 2-diol is frequently used in drug screening programs to evaluate its impact on cell viability and its potential as a lead compound for therapeutic development Experimental concentrations typically depend on the specific research design